Ken Griffin Omnicell, Inc Call Options Transaction History

Citadel Advisors LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$26.22 - $32.65 $99,636 - $124,070	3,800 Added 29.92%	16,500 $446,000
Q1 2024 May 15, 2024	BUY	$26.15 - $37.33 $62,760 - $89,592	2,400 Added 23.3%	12,700 $371,000
Q4 2023 Feb 14, 2024	SELL	$29.24 - $45.81 $716,380 - $1.12 Million	-24,500 Reduced 70.4%	10,300 $387,000
Q3 2023 Nov 14, 2023	SELL	$44.6 - $73.38 $1.12 Million - $1.85 Million	-25,200 Reduced 42.0%	34,800 $1.57 Million
Q2 2023 Aug 14, 2023	BUY	$57.88 - $75.94 $2.44 Million - $3.2 Million	42,200 Added 237.08%	60,000 $4.42 Million
Q1 2023 May 15, 2023	BUY	$51.51 - $60.43 $458,439 - $537,827	8,900 Added 100.0%	17,800 $1.04 Million
Q4 2022 Feb 14, 2023	SELL	$46.24 - $90.03 $1.35 Million - $2.64 Million	-29,300 Reduced 76.7%	8,900 $448,000
Q3 2022 Nov 14, 2022	BUY	$84.23 - $117.38 $2 Million - $2.78 Million	23,700 Added 163.45%	38,200 $3.33 Million

262

45.9M

153K

33.2K

Ticker OMCL
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 44,288,800
Market Cap $2.34B
Description
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensi...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.